May 2, 2018
Yesterday, the Naomi Berrie Diabetes Center at Columbia University hosted a research panel discussion in New York City. Highlights of that meeting are presented in this report. Click here to view.
April 20, 2018
This report provides an update on Stem Cells Arabia (SCA), a private company in Amman, Jordan that is conducting human trials research toward a T1D cure using the “Jordanian Method for Treatment of Diabetes.” Click here to view.
April 12, 2018
Yesterday, a widely published press release announced a new partnership between Eli Lilly and Sigilon Therapeutics, a private biopharmaceutical company working on a unique cell encapsulation approach. Click here to view.
March 8, 2018
This is the sixth annual survey-based report on the giving priorities of T1D donors. The key takeaway is the same as all prior years: the number one reason people make donations to diabetes charities and/or participate in fundraising activities such as walks and galas is to find a cure. Click here to read more.
February 22, 2018
This is a third in a series of reports on JDRF financials. The main takeaway is that JDRF administration cost for each dollar of actual research grants have increased 115 percent since 2008 while research grant spending is down 49 percent. Click here to read more.
January 31, 2018
This report addresses an infographic in which JDRF claims it is responsible for $300 million dollars of research spending in 2017, rather than the $79 million reported in their audited financial statements. Click here to read more.
January 19, 2018
This report provides an overview of JDRF's 2017 financial statements, released this week. Based on publicly available tax and financial documents, it show how JDRF generates its revenue and how it utilizes those funds. Click here to read more.